# Efficacy Study of Cyclosporine Ophthalmic Emulsion in Patients With Dry Eye Disease

> **NCT00717418** · — · COMPLETED · sponsor: **Allergan** · enrollment: 781 (actual)

## Conditions studied

- Keratoconjunctivitis Sicca

## Interventions

- **DRUG:** cyclosporine ophthalmic emulsion 0.05%, artificial tears

## Key facts

- **NCT ID:** NCT00717418
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2006-08
- **Final completion:** 2008-08
- **Target enrollment:** 781 (ACTUAL)
- **Last updated:** 2012-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00717418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00717418, "Efficacy Study of Cyclosporine Ophthalmic Emulsion in Patients With Dry Eye Disease". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00717418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*